On September 7, 2021 Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, reported that the Company will participate in the following upcoming virtual investor conferences (Press release, Poseida Therapeutics, SEP 7, 2021, View Source [SID1234587352]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H. C. Wainwright 23rd Annual Global Investment Conference
Date: On-demand session opens Monday, September 13, 2021
Time: 7:00am ET

Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 27, 2021
Time: 8:40am ET

Webcasts will be available on the Investors & Media Section of the Poseida website, www.poseida.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.